CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Korea United Pharmaceutical Incorporated Company Snapshot
Korea United Pharmaceutical Incorporated operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Korea United Pharmaceutical Incorporated with three other companies in this sector in KOREA (SOUTH) : Samjin Pharmaceutical Company Limited (2019 sales of 241.93 billion Korean Won [US$211.69 million] of which 62% was Tablet), Shin Poong Pharmaceutical Co., Ltd. (189.72 billion Korean Won [US$166.01 million] of which 73% was Completed Medicine), and Yungjin Pharm Co Ltd (220.52 billion Korean Won [US$192.95 million] of which 100% was The manufacture and distribution of phar).

Sales Analysis. Korea United Pharmaceutical Incorporated reported sales of 221.31 billion Korean Won (US$193.65 million) for the year ending December of 2019. This represents an increase of 4.4% versus 2018, when the company's sales were 211.94 billion Korean Won . Sales at Korea United Pharmaceutical Incorporated have increased during each of the previous five years (and since 2014, sales have increased a total of 43%). Sales of Glicetil saw an increase that was more than double the company's growth rate: sales were up 32.9% in 2019, from 4.49 billion Korean Won to 5.97 billion Korean Won . Korea United Pharmaceutical Incorporated also saw significant increases in sales in Cilostan (up 10.5% to 35.81 billion Korean Won ) and Anticancer Drug (up 8.1% to 23.71 billion Korean Won ) and Castiin (up 16.6% to 19.29 billion Korean Won ) . Not all segments of Korea United Pharmaceutical Incorporated experienced an increase in sales in 2019: sales of Clanza fell 6.5% to 7.68 billion Korean Won . (However, this segment's sales were only a very small portion of the company's overall sales). Korea United Pharmaceutical Incorporated also experienced decreases in sales in Othe Proucts (down 1.4% to 97.41 billion Korean Won ) and Newbutin (down 1.2% to 6.27 billion Korean Won ) and Omnihexol Inj. (down 0.9% to 6.07 billion Korean Won ) .
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Korea United Pharmaceutical Incorporated
  Stock Performance Chart for Korea United Pharmaceutical Incorporated
 
  Stock Data: Recent Stock Performance:
  Current Price (10/16/2020): 49,950
(Figures in Korean Won )
1 Week -30.2%   13 Weeks -42.9%  
4 Weeks 97.8%   52 Weeks 152.9%  
 
Korea United Pharmaceutical Incorporated Key Data:
  Ticker: 033270 Country: Korea (South)
  Exchanges: SEO Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2019 Sales 221,310,874,550
(Year Ending Jan 2020).
Employees: 873
  Currency: Korean Won Market Cap: 740,770,937,550
  Fiscal Yr Ends: December Shares Outstanding: 14,830,249
  Share Type: Common Closely Held Shares: 6,062,053
 
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.